+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Analgesics in Singapore

  • PDF Icon


  • 25 Pages
  • October 2023
  • Region: Singapore
  • Euromonitor International
  • ID: 4432201
Due to the high rates of vaccination amongst Singaporeans, systemic analgesics were purchased in high quantities in 2022 to fulfil the demand to self-medicate amidst post-vaccination symptoms and common cold symptoms from later variants of the pandemic. In 2023, however, with the threat of COVID-19 largely mitigated, the growth rate of systemic analgesics is set to normalise, and topical analgesics/anaesthetic will be the category that stands to see a higher increase in current value sales.

The Analgesics in Singapore report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

  • Topical analgesics/anaesthetic is the top-performing category, while growth for systemic analgesics eases
  • Increased travel enables rebound for herbal/traditional topical analgesics/